Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

White matter astrocytes in health and disease.
Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.
Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.
The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells.
JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level.
Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis.
Prevention and treatment of MS: studying the effects of vitamin D.
Identification of Selective Inhibitors of the Potassium Channel Kv1.1-1.2((3)) by High-Throughput Virtual Screening and Automated Patch Clamp.
Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: A randomized controlled clinical trial.
A high-density screen for linkage in multiple sclerosis.
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.
BRIEF-AB Science says DSMB recommends continuation of phase 3 masitinib study
The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community.
Guillain-Barré syndrome-like-onset neurosarcoidosis positive for immunoglobulin G anti-N-acetylgalactosaminyl-GD1a antibody.
Potassium-Retaining Diuretics: Amiloride
Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease.
Substance Name: Amiloride
Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial.
GeNeuro and Servier sign partnership to develop first medicine addressing a causal factor of multiple sclerosis
Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
Receptos Reports Positive Phase 2 Results for TOUCHSTONE Trial of RPC1063 in Ulcerative Colitis
Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.
Epigenetic mechanisms in multiple sclerosis and the major histocompatibility complex (MHC).
Prolonged Remission in Neuromyelitis Optica Following Cessation of Rituximab Treatment.

Pages